
Highlights by Sakditad Saowapa from ASCO GU25
The 2025 ASCO Genitourinary (GU) Cancers Symposium takes place from February 13 to 15, featuring interactive sessions focused on cutting-edge research, multidisciplinary expertise, and evidence-based practices in GU cancer care. ASCO, the American Society for Radiation Oncology, and the Society of Urologic Oncology cosponsor the symposium.
Sakditad Saowapa, Resident Physician at Texas Tech University Health Sciences Center, shared some insights the the Symposium:
“Rocking the last day of GU25”
“Ready to rock the last day of GU25!
Let’s make it fun and refreshing at the ASCO Genitourinary Cancers
Symposium for renal cancer day.”
“faster PSA rises increase the chance of true positives”
“PSMA PET scans can be tricky with false positives, but faster PSA rises increase the chance of true positives.
Expected spread patterns usually hold true, and no PSMA agent stands out yet. Standardized reporting helps!”
“PSMA PET vs. Conventional Imaging”
“PSMA PET vs. Conventional Imaging:
PSMA PET offers superior accuracy, sensitivity, and specificity for detecting metastases in high-risk patients in RCT, while 18F-Fluciclovine is approved for biochemical recurrent disease detection, not initial staging.
WB-MRI excels in bone lesion detection but is less sensitive for nodal lesions compared to PSMA imaging.
Case-Based Session: Evolving Landscape of the Management of Oligometastatic Disease (Prostate Cancer).”
“Interesting session on gut health and prostate cancer”
“Super interesting session on gut health and prostate cancer!
Ab311 by Dr. Robert J. Thomas.
Study shows that boosting phytochemical-rich foods with a specific supplement slows PSA progression and improves urinary symptoms.
World’s first robust RCT indicates a lactobacillus supplement further reduces PSA progression.
Exciting findings with longer-term follow-up needed for low-risk men. Self-help nutrition advice welcomed!”
“Driving Science to Improve Patient-Centered Care”
“Creative Innovation: Driving Science to Improve Patient-Centered Care by Bill Dahut starting now!!
At general session 3rd floor Moscone West San Francisco.”
“QOL matters in every decision”
“QOL matters in every decision!
Let’s make treatment choices that keep them smiling.
Great session indeed!”
“Thanks for the great catch-up,
Dr. Christopher Wee from Cleveland Clinic at GU25!
Your support during my medical oncology away rotation and the letter of recommendation for my heme/onc fellowship training were invaluable.
Couldn’t have done it without your help!”
More posts featuring Sakditad Saowapa and ASCO GU25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023